Reduction of bilirubin by targeting human heme oxygenase-1 through siRNA

Experimental Biology and Medicine

Volumn 232, Issue 4, 2007, Pages 495-502

  Xia, Zhen Wei ^a,d   Li, Chun E ^a   Jin, You Xin ^b   Shi, Yi ^b   Xu, Li Qing ^a   Zhong, Wen Wei ^a   Li, Yun Zhu ^a   Yu, Shan Chang ^a   Zhang, Zi Li ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Bilirubin; Heme oxygenase; Hyperbilirubinemia; RNA mediated interference; Small interfering RNA

Indexed keywords

BILIRUBIN; HEME OXYGENASE 1; HEMIN; SMALL INTERFERING RNA;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

BILIRUBIN; CELL LINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEME OXYGENASE-1; HEMIN; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; KERNICTERUS; LIVER; OXIDATION-REDUCTION; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 34047167614     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Dennery PA. Pharmacological interventions for the treatment of neonatal jaundice. Semin Neonatol 7:111-119, 2002.
2. Riskin A, Kugelman A, Abend-Weinger M, Green M, Hemo M, Bader D. In the eye of the beholder: how accurate is clinical estimation of jaundice in newborns? Acta Paediatr 92:574-576, 2003.
3. Gourley GR. Breast-feeding, neonatal jaundice and kernicterus. Semin Neonatol 7:135-141, 2002.
4. Watchko JF, Daood MJ, Biniwale M. Understanding neonatal hyperbilirubinaemia in the era of genomics. Semin Neonatol 7:143-152, 2002.
5. Drummond GS, Kappas A. An experimental model of postnatal jaundice in the suckling rat. Suppression of induced hyperbilirubinemia by Sn-protoporphyrin. J Clin Invest 74:142-149, 1984.
6. Alexander D. A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin. Pediatrics 113:135, 2004.
7. Sharp PA. RNA interference. Genes Dev 15:485-490, 2001.
8. Hannon GJ. RNA interference. Nature 418:244-251, 2002.
9. Alisky JM, Davidson BL. Towards therapy using RNA interference. AM J Pharmacogenomics 4:45-51, 2004.
10. Xia ZW, Qi Q, Zhang XH, Shen QX, Li YZ, Yu SC. The study on the construction of expression plasmid containing rHO-1 cDNA, analysis of rHO-1 activity and function of anti-apoptosis in HUVEC. Shi Yan Sheng Wu Xue Bao 38:441-446, 2005.
11. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, Vercellotti GM. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 267:18148-18153, 1992.
12. Sarici SU, Serdar MA, Korkmaz A, Erdem G, Oran O, Tekinalp G, Yurdakok M, Yigit S. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics 113:775-780, 2004.
13. Setia S, Villaveces A, Dhillon P, Mueller BA. Neonatal jaundice in Asian, white, and mixed-race infants. Arch Pediatr Adolesc Med 156:276-279, 2002.
14. Agarwal R, Deorari AK. Unconjugated hyperbilirubinemia in newborns: current perspective. Indian Pediatr 39:30-42, 2002.
15. Maines MD, Gibbs PE. 30 some years of heme oxygenase: from a "molecular wrecking ball" to a "mesmerizing" trigger of cellular events. Biochem Biophys Res Commun 338:568-577, 2005.
16. Maisels MJ, Watchko JF. Treatment of jaundice in low birthweight infants. Arch Dis Child Fetal Neonatal Ed 88:F459-F463, 2003.
17. Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinemia. N Engl J Med 344:581-590, 2001.
18. Hansen TW. Recent advances in the pharmacotherapy for hyperbilirubinaemia in the neonate. Expert Opin Pharmacother 4:1939-1948, 2003.
19. Patra K, Storfer-Isser A, Siner B, Moore J, Hack M. Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr 144:626-631, 2004.
20. Dani C, Masini E, Bertini G, di Felice AM, Pezzati M, Ciofini S, Rossetti M, Gallori G, Ciuti R, Buonocore G, Paffetti P, Mannaioni PF, Rubaltelli FF. Role of heme oxygenase and bilirubin in oxidative stress in preterm infants. Pediatr Res 56:873-877, 2004.
21. Zampetaki A, Minamino T, Mitsialis SA, Kourembanas S. Effect of heme oxygenase-1 overexpression in two models of lung inflammation. Exp Biol Med (Maywood) 228:442-446, 2003.
22. Dennery PA. Metalloporphyrins for the treatment of neonatal jaundice. Curr Opin Pediatr 17:167-169, 2005.
23. Saetrom P, Snove O Jr. A comparison of siRNA efficacy predictors. Biochem Biophys Res Commun 321:247-253, 2004.
24. Du Q, Thonberg H, Wang J, Wahlestedt C, Liang Z. A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites. Nucleic Acids Res 33:1671-1677, 2005.
25. Persengiev SP, Zhu X, Green MR. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10:12-18, 2004.
26. Holen T, Amarzguioui M, Wiiger MT, Babaie E, Prydz H. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res 30:1757-1766, 2002.
27. Drummond GS, Kappas A. An experimental model of postnatal jaundice in the suckling rat. Suppression of induced hyperbilirubinemia by Sn-protoporphyrin. J Clin Invest 74:142-149, 1984.
28. Onodera Y, Takahashi K, Togashi T, Sugai Y, Tamaki N, Miyasaka K. Clinical assessment of hepatic functional reserve using 99mTc DTPA galactosyl human serum albumin SPECT to prognosticate chronic hepatic diseases - validation of the use of SPECT and a new indicator. Ann Nucl Med 17:181-188, 2003.